Kosuke Kashiwabara

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function

Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada et al. · Liver Cancer · 2017 · 319 citations · Full text

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2021 · 238 citations

Systemic Scleroderma, Systemic Treatment, Immunology +6

Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial)

Tadatoshi Takayama, Kiyoshi Hasegawa, Namiki Izumi et al. · Liver Cancer · 2021 · 174 citations · Full text

An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer

Takahiro Karasaki, Kazuhiro Nagayama, Hideki Kuwano et al. · Journal of Thoracic Oncology · 2017 · 165 citations

Cancer Immunosurveillance, Medicine, Immunology +11

Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large phase III randomized trials

Toru Aoyama, Koji Oba, Michitaka Honda et al. · Cancer Medicine · 2017 · 121 citations · Full text